Evidence map›Paper›PMID 38189293›Full record

ArticleMicrobiology spectrum2024

Multimodal vaccination targeting the receptor binding domains of

Kaitlin Winter, Sébastien Houle, Charles M Dozois, Brian J Ward

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaitlin WinterDepartment of Microbiology and Immunology, McGill University, Montreal, Québec, Canada.ORCID 0000-0002-2626-1730
Sébastien HouleInstitut National de Recherche Scientifique-Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada.
Charles M DozoisInstitut National de Recherche Scientifique-Centre Armand-Frappier Santé Biotechnologie, Laval, Québec, Canada.ORCID 0000-0003-4832-3936
Brian J WardDepartment of Microbiology and Immunology, McGill University, Montreal, Québec, Canada.ORCID 0000-0003-3251-958X

Funding

Aviex Technologies LLC IPR-144157Faculty of Medicine, McGill University (McGill Faculty of Medicine)FRQ | Fonds de Recherche du Québec - Santé (FRQS)Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) IPR-144157Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC)
6 · The paper itself

Abstract

Developing a vaccine against

Indexed as

Bacterial ToxinsBoron CompoundsClostridioides difficileAgedAnimalsBacterial VaccinesHumansImmunoglobulin AImmunoglobulin GMiceSalmonella typhimuriumVaccinationVaccines, SyntheticBacterial ToxinsBacterial VaccinesBoron CompoundsImmunoglobulin AImmunoglobulin GtrimethylaminocarboxyldihydroboranVaccines, Syntheticchromosomal integrationClostridioides difficilehumoral immunitymucosal immunitySalmonella Typhimuriumvaccination

Identifiers

PMID38189293
PMCPMC10846063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.